 1. Patients who have a diagnosis of another hereditary thrombophilic disorder e.g. activated protein CAPC resistanceFactor V Leiden, Protein S or C deficiency, prothrombin gene mutation G20210A, or acquired lupus anticoagulant thrombophilic disorder. 